InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: Titan V post# 42200

Tuesday, 11/28/2017 9:53:13 AM

Tuesday, November 28, 2017 9:53:13 AM

Post# of 48316
Any new patents filed are a plus. Daniel J. O'Connor, Chief Executive Officer of OncoSec. "We are pleased with the progress of the ongoing PISCES/KEYNOTE-695 clinical trial which benefits, in part, from the second issued patent."

Sounds like the PISCES enrollment is moving along okay.